1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > Diagnostic Imaging Market Trends
Contrast Media/Contrast Agent Market by Type, Modality, Application, End User, Indication, Route of Administration, Region - Global Forecast to 2026

Contrast Media/Contrast Agent Market by Type, Modality, Application, End User, Indication, Route of Administration, Region - Global Forecast to 2026

  • July 2021
  • 287 pages
  • ID: 5223264
  • Format: PDF
  • MarketsandMarkets

Summary

Table of Contents

Search Inside

The global contrast media/ contrast agents market is projected to reach USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period. The growth in this market can be attributed to the rising prevalence of chronic diseases, growing approvals of contrast agents, rising volume of CT and MRI examinations performed, growing number of diagnostic centers and hospitals, and availability of reimbursement. Emerging markets in Asian countries are expected to offer strong growth opportunities for players in the market. In contrast, high cost and inaccessibility of advanced therapeutics may restrict market growth to a certain extent. The contrast media/ contrast agents market is segmented based on type, modality, route of administration, indication, application, end user, and region.

Iodinated contrast media segment is expected to dominate the market during the forecast period.
Based on type, the contrast media/ contrast agents market is segmented into iodinated contrast media, gadolinium-based contrast media, microbubble contrast media, and barum-based contrast media.Iodinated contrast media account for the largest share of the contrast media/ contrast agents market.

The large share of this segment can be attributed to the growing number of angioplasty procedures performed globally.

X-ray/ CT segment to dominate the market during the forecast period.
Based on modality, contrast media/ contrast agents can be segmented into X-ray/CT, MRI and Ultrasound.X-ray/CT account for the largest share of the contrast media/ contrast agents market. The large share of this segment can be attributed to the increasing number of CT examinations across the globe, coupled with advancements in CT imaging technologies that majorly use injectable contrast media.

Intravascular route segment holds highest market share during the forecast period and is also expected to grow at the highest CAGR during the forecast period.
Based on routes of administration, the contrast media/contrast agents market is segmented into oral, intravascular, rectal, and other routes of administration.The intravascular route segment is expected to hold majority of market share and have highest growth rate.

The widespread use of injectable contrast media in most modern imaging modalities, such as CT and MRI scanning, is one of the major factors driving the growth of the intravascular segment.

Cardiovascular disorders segment holds highest market share during the forecast period and is also expected to grow at the highest CAGR during the forecast period.
Based on indication, the contrast media/contrast agents market has been segmented into cardiovascular disorders, cancer, gastrointestinal disorders, musculoskeletal disorders, neurological disorders, and nephrological disorders.Cardiovascular disorders accounted for the largest market share and highest growth rate.

The large share of this segment can be attributed to the rising geriatric population and the increasing prevalence of CVD across the globe.

Radiology segment to dominate the market during the forecast period.
Based on application, the contrast media/contrast agents market is segmented into radiology, interventional radiology, and interventional cardiology.The radiology applications segment commanded the largest share of the contrast media/contrast agents market. .The large share of this segment can be attributed to the increasing use of medical imaging techniques, such as X-ray, CT, MRI, and ultrasound, in these applications.

Hospitals, Clinics & Ambulatory Surgery Centers segment to dominate the market during the forecast period.
Based on end user, the contrast media/contrast agents market is segmented into hospitals, clinics, and ASCs and diagnostic imaging centers.Hospitals, clinics, and ASCs for the largest share of the contrast media/ contrast agents market.

The large share is attributed to rising number of hospitals across the globe.

North America will dominate the market during the forecast period.
The global contrast media/ contrast agents market is segmented into North America (the US and Canada), Europe (Germany, the UK, France, Italy, Spain and the Rest of Europe), Asia Pacific (Japan, China, India, and the Rest of Asia Pacific), Latin America and Middle East & Africa.In 2020, North America dominated the global contrast media/ contrast agents market, followed by Europe.

The large share of the North American market can be attributed to the presence of major players in the region, high prevalence of chronic disorders, growing geriatric population, and the increasing adoption of minimally invasive procedures.

The primary interviews conducted for this report can be categorized as follows:
• By Company Type -Tier 1: 55%,Tier 2: 25% and Tier 20%
• By Designation - C-level:43%, D-level:32%, and Others:25%
• By Region - North America:38%, Europe:23%, Asia Pacific:29%, Latin America: 7%, and Middle East & Africa: 3%

List of Companies Profiled in the Report
• GE Healthcare (US)
• Bracco Imaging SPA (Italy)
• Bayer AG (Germany)
• Guerbet (France)
• Lantheus Medical Imaging, Inc. (US)
• Unijules Life Sciences (India)
• J.B. Chemicals and Pharmaceuticals Ltd. (India)
• SANOCHEMIA Pharmazeutika GmbH (Austria)
• Taejoon Pharm (South Korea)
• JodasExpoim (India)
• Nano Therapeutics Pvt. Ltd. (India)
• Kiran X-ray (India)
• iMax Diagnostic Imaging Limited (Ireland)
• YZJ Group (China)
• Livealth Biopharma Pvt. Ltd. (India)
• Trivitron Healthcare Pvt. Ltd. (India)
• Novalek Pharmaceuticals Pvt. Ltd. (India)
• Unispire Biopharma Private Limited (India)
• Acro Lifesciences (I) Pvt. Ltd. (India)
• Congruent Pharmachem Private Limited (India)
• Stanex Drugs & Chemical Pvt. Ltd. (India)
• Beijing Beilu Pharmaceutical Co., Ltd. (China)
• Rege Imaging & Cine Films Private Limited (India)
• K DIAM EXIM (India)
• Onko ?laç San. ve Tic. A.?. (Turkey)
• Subhra Pharma Pvt. Ltd. (India)

Research Coverage:
This report provides a detailed picture of the global contrast media/ contrast agentsmarket.It aims at estimating the size and future growth potential of the market across different segments, such astype, modality, route of administration, indication, application, end userand region.

The report also analyzes factors (such as drivers, restraints,opportunities and challenges) affecting market growth.It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders.

The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total contrast media/ contrast agents market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on contrast media/ contrast agents offered by the top 26 players in the contrast media/ contrast agents market. The report analyses the contrast media/ contrast agentsmarket by product, modality, route of administration, indication, application, end userand region.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various contrast media/ contrast agentsacross key geographic regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media/ contrast agentsmarket.
• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the contrast media/ contrast agentsmarket.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Infertility Treatment Market by Product, Procedure, Insemination, Laparoscopy, Hysteroscopy, Patient Type, End User - Global Forecast to 2026

  • $ 4950
  • October 2021
  • 248 pages

The global infertility treatment market size is projected to reach USD 2.2 billion by 2026 from USD 1.5 billion in 2021, at a CAGR of 8.1 % during the forecast period. Factors such as decline in the fertility ...

  • World
  • Europe
  • Healthcare
  • Urology
  • Industry analysis
  • Fertility Rate
  • Health Expenditure

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on